AAC Accepted Manuscript Posted Online 17 August 2020 Antimicrob. Agents Chemother. doi:10.1128/AAC.01025-20 Copyright © 2020 American Society for Microbiology. All Rights Reserved. 1 Achromobacter Infections and Treatment Options 2 Burcu Isler 1 2,3 3 Timothy J. Kidd Downloaded from 4 Adam G. Stewart 1,4 5 Patrick Harris 1,2 6 1,4 David L. Paterson http://aac.asm.org/ 7 1. University of Queensland, Faculty of Medicine, UQ Center for Clinical Research, 8 Brisbane, Australia 9 2. Central Microbiology, Pathology Queensland, Royal Brisbane and Women’s Hospital, 10 Brisbane, Australia on August 18, 2020 at University of Queensland 11 3. University of Queensland, Faculty of Science, School of Chemistry and Molecular 12 Biosciences, Brisbane, Australia 13 4. Infectious Diseases Unit, Royal Brisbane and Women’s Hospital, Brisbane, Australia 14 15 Editorial correspondence can be sent to: 16 Professor David Paterson 17 Director 18 UQ Center for Clinical Research 19 Faculty of Medicine 20 The University of Queensland 1 21 Level 8, Building 71/918, UQCCR, RBWH Campus 22 Herston QLD 4029 AUSTRALIA 23 T: +61 7 3346 5500 Downloaded from 24 F: +61 7 3346 5509 25 E:
[email protected] 26 http://aac.asm.org/ 27 28 29 on August 18, 2020 at University of Queensland 30 31 32 33 34 35 36 37 38 39 2 40 Abstract 41 Achromobacter is a genus of non-fermenting Gram negative bacteria under order 42 Burkholderiales. Although primarily isolated from respiratory tract of people with cystic Downloaded from 43 fibrosis, Achromobacter spp. can cause a broad range of infections in hosts with other 44 underlying conditions.